Cargando…
Lipid Nanocarrier-Based Drug Delivery Systems: Therapeutic Advances in the Treatment of Lung Cancer
Although various treatments are currently being developed, lung cancer still has a very high mortality rate. Moreover, while various strategies for the diagnosis and treatment of lung cancer are being used in clinical settings, in many cases, lung cancer does not respond to treatment and presents re...
Autores principales: | Kim, So-Jung, Puranik, Nidhi, Yadav, Dhananjay, Jin, Jun-O, Lee, Peter C W |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202211/ https://www.ncbi.nlm.nih.gov/pubmed/37223276 http://dx.doi.org/10.2147/IJN.S406415 |
Ejemplares similares
-
The Ubiquitin System: An Emerging Therapeutic Target for Lung Cancer
por: Jin, Jun-O, et al.
Publicado: (2021) -
Advancements in the Application of Nanomedicine in Alzheimer’s Disease: A Therapeutic Perspective
por: Puranik, Nidhi, et al.
Publicado: (2023) -
Recent Advances in Nanocarrier-Assisted Therapeutics Delivery Systems
por: Su, Shi, et al.
Publicado: (2020) -
Multifunctional Nanocarriers for Lung Drug Delivery
por: Pontes, Jorge F., et al.
Publicado: (2020) -
Modulating the Ubiquitin–Proteasome System: A Therapeutic Strategy for Autoimmune Diseases
por: Yadav, Dhananjay, et al.
Publicado: (2022)